Study shows that when diagnosing knee cartilage defects, 3D and 2D MRIs performed about the same.
Three-dimensional MRI is comparable to two-dimensional MRI in the depiction and characterization of cartilage defects within the knee joint, according to a study published in the journal Radiology.
Researchers from the United States and Iran sought to determine the diagnostic performance of 3D MRI for the depiction and characterization of cartilage defects within the knee joint. This was compared to arthroscopy and/or open surgery as the standard of reference.
The researchers performed a systematic literature search for diagnostic studies published between January 1985 and October 2017. Two independent investigators assessed the methodologic quality of each study by using Quality Assessment of Diagnostic Accuracy Studies 2. The researchers compared the diagnostic odds ratio (DOR) of 3D and two-dimensional (2D) MRI for helping to detect knee cartilage defects and to assess the effect of relevant covariates on diagnostic performance of 3D MRI.
Related article: Study: In-Hospital MRIs Could Be Wasteful
Thirty-seven studies comprising 1,710 MRI examinations were included. Of those, 16 (59%) studies compared the diagnostic performance of 3D and 2D MRI. The diagnostic performance of 3D MRI statistically significantly improved over the last 3 decades. Three-dimensional MRI obtained by using 3.0-T field strength had higher DOR relative to 1.5-T or lower field strength (relative DOR, 4.05). Three-dimensional multiplanar reformation was associated with higher specificity compared with conventional axial, sagittal, and coronal 2D MRI planes. Three-dimensional fast-spin-echo sequences provided higher sensitivity and specificity than did 2D MRI.
The researchers concluded that 3D MRI provided comparable diagnostic performance to two-dimensional MRI, with improvement in diagnostic performance achieved by using 3.0-T field strength, three-dimensional fast-spin-echo sequences, and multiplanar reformation.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.